EXACT SCIENCES CORP — Director's Dealing 2017

Sep 7, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXACT SCIENCES CORP (EXAS)
CIK: 0001124140
Period of Report: 2017-09-05

Reporting Person: LIDGARD GRAHAM PETER (Chief Science Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-09-05	Common Stock	M	19425	$9.07	Acquired	308377	Direct
2017-09-05	Common Stock	M	30258	$10.82	Acquired	338635	Direct
2017-09-05	Common Stock	M	12250	$23.38	Acquired	350885	Direct
2017-09-05	Common Stock	M	13750	$5.70	Acquired	364635	Direct
2017-09-05	Common Stock	S	73983	$40.80	Disposed	290652	Direct
2017-09-05	Common Stock	S	1700	$41.35	Disposed	288952	Direct
2017-09-06	Common Stock	M	33075	$9.07	Acquired	322027	Direct
2017-09-06	Common Stock	M	9242	$10.82	Acquired	331269	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-09-05	Stock Option (right to buy)	$9.07	M	19425	Disposed	2022-02-27	Common Stock (19425)	Direct
2017-09-05	Stock Option (right to buy)	$10.82	M	30258	Disposed	2023-02-22	Common Stock (30258)	Direct
2017-09-05	Stock Option (right to buy)	$23.38	M	12250	Disposed	2025-03-09	Common Stock (12250)	Direct
2017-09-05	Stock Option (right to buy)	$5.70	M	13750	Disposed	2026-02-26	Common Stock (13750)	Direct
2017-09-06	Stock Option (right to buy)	$9.07	M	33075	Disposed	2022-02-27	Common Stock (33075)	Direct
2017-09-06	Stock Option (right to buy)	$10.82	M	9242	Disposed	2023-02-22	Common Stock (9242)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	12014	Indirect

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2017.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.315 to $41.295, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.30 to $41.42, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.

F4: This option vested in four equal annual installments beginning on February 27, 2013.

F5: This option vested in four equal annual installments beginning on February 22, 2014.

F6: This option vests in four equal annual installments beginning on March 9, 2016.

F7: This option vests in four equal annual installments beginning on February 26, 2017.